Table 2.
Agent (Form) | Species, strain | Sex | Age (weeks) | Exposure, Vehicle | Doses Tested, length of exposure | Endpoints | Reference |
---|---|---|---|---|---|---|---|
Chemical Factors | |||||||
Metals | |||||||
Inorganic Mercury (HgCl2) | Mouse, B10.S, SJL, others | M, F | 6–8 | Injection s.c., saline | 1.6 mg/kg two to three times/week for 4 weeks | Disease induction: serum Igs, autoAb, immune deposits | Kono DH et al, 1998 [15] Abedi-Valugerdi M et al 2001 [14] |
Inorganic Mercury (HgCl2) | Mouse, NZBWF1 | F | 4–8 | Injection s.c., saline | 1.6 mg/kg two to three times/week for 4 weeks | Disease exacerbation: serum Igs, autoAb, immune deposits | Al-Balaghi S et al, 1996 [85] Pollard KM et al, 1999 [86] |
Adjuvants | |||||||
TMPD (Pristane) | Rat, Dark Agouti, others | M, F | 8–14 | S.c. or intradermal, saline | 150 ul X 1, up to 1 year | Disease induction: arthrits | Olofsson P and Holmdahl R, 2007 [32] |
TMPD (Pristane) | Mouse, BALB/c, others | M, F | 8–12 | i.p., saline | 0.5 ml, up to 9 months | Disease induction: serum Igs, autoAb, immune deposits, arthritis | Satoh M et al, 2000 [35] Clynes R et al, 2005 [34] |
Biological Factors | |||||||
Associated Infections | |||||||
Streptococ cus group A | Mouse, BALB/c, | M/F | 4–8 | s.c./PBS | 0.5mg M protein peptides/8 weeks | Disease induction: AutoAbs, myocarditis | Cunningham MW et al, 2001 [57] |
Rat, Lewis | F | 8–12 | s.c. or i.p./CFA | 0.5 mg recombinant M protein/17–21 days | Disease induction: Lymphocyte proliferation, Valvulitis/carditis | Gorton D et al, 2009 [62] Quinn A et al, 2001 [60] |
|
Coxsackie B virus | Mouse, BALB/c, others | M/F | 4–8 | i.p./PBS | 1×103 PFU (Nancy strain) CVB3 up to 56 days | Disease induction: AutoAbs, mycarditis | Esfandiarei M et al, 2008 [69] |
Dietary Factors | |||||||
Iodine | Mouse, NOD-H2h4 | M, F | 6–8 | Oral, water | 0.05% iodine for up to 8 weeks | Disease exacerbation: AutoAbs, thyroiditis | Rasooly L et al, 1996 [52] Hutchings PR et al, 1999 [51] McLachlan SM et al, 2005 [49] |